The store will not work correctly when cookies are disabled.
6-Methoxy-2-methyl-4-(2-(pyridin-3-ylmethylene)hydrazinyl)quinoline
ID: ALA4514167
Cas Number: 29125-41-5
PubChem CID: 9555351
Max Phase: Preclinical
Molecular Formula: C17H16N4O
Molecular Weight: 292.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2nc(C)cc(N/N=C/c3cccnc3)c2c1
Standard InChI: InChI=1S/C17H16N4O/c1-12-8-17(21-19-11-13-4-3-7-18-10-13)15-9-14(22-2)5-6-16(15)20-12/h3-11H,1-2H3,(H,20,21)/b19-11+
Standard InChI Key: ZXVHYKHTAQEISS-YBFXNURJSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
13.9280 -4.5853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9268 -5.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6349 -5.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6331 -4.1765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3417 -4.5817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3425 -5.4007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0510 -5.8078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7593 -5.3970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7545 -4.5748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0454 -4.1715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4686 -5.8028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0411 -3.3543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7466 -2.9420 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2202 -4.1769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2200 -3.3597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4565 -3.3468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1620 -2.9345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8704 -3.3441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5754 -2.9325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5715 -2.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8567 -1.7098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1546 -2.1238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
10 12 1 0
12 13 1 0
1 14 1 0
14 15 1 0
13 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.34 | Molecular Weight (Monoisotopic): 292.1324 | AlogP: 3.39 | #Rotatable Bonds: 4 |
Polar Surface Area: 59.40 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.42 | CX LogP: 2.71 | CX LogD: 2.41 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.59 | Np Likeness Score: -1.60 |
References
1. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S.. (2019) Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)., 182 [PMID:31514018] [10.1016/j.ejmech.2019.111649] |